Prostate cancer can spread to the colon and rectum, though it does so rarely. Autopsy studies have found rectal involvement from prostate cancer in roughly 4% of patients. When it happens, the spread typically reaches the rectum first because of the prostate’s close physical proximity, but it can also appear in other parts of the colon.
How Prostate Cancer Reaches the Colon
The prostate sits directly in front of the rectum, separated by a thin sheet of tissue called Denonvilliers’ fascia. This fascia acts as a physical barrier between the two organs. In most cases, it keeps prostate tumors from growing into rectal tissue. But as a tumor becomes more advanced or aggressive, it can break through this barrier and invade the rectal wall directly. This direct extension is the most common route of spread to the colon.
The second pathway is through lymphatic channels. The prostate and rectum share some of their lymphatic drainage, meaning they connect to the same groups of pelvic lymph nodes. Prostate cancer cells can travel through these shared channels and establish themselves in tissue around or within the rectum. One small study found that about 4.5% of cases initially thought to be rectal cancer in pelvic lymph nodes turned out to be metastatic prostate cancer instead.
A third, much rarer route involves needle biopsy seeding. During a transrectal prostate biopsy, the needle passes through the rectal wall to reach the prostate. In extremely uncommon cases, cancer cells can be deposited along the needle track into rectal or perirectal tissue.
Symptoms of Rectal Involvement
The tricky part of prostate cancer spreading to the colon is that the symptoms can look exactly like a primary colorectal problem. Patients may notice rectal bleeding, changes in bowel habits such as new constipation or narrowing of stool, a persistent feeling of needing to have a bowel movement even after one, or difficulty passing stool. Because these symptoms overlap so heavily with conditions like hemorrhoids, inflammatory bowel disease, or colon cancer, rectal involvement from prostate cancer is often not the first thing anyone suspects.
In some cases, the spread causes no bowel symptoms at all and is discovered incidentally during imaging or a colonoscopy done for other reasons.
How It’s Identified
Colonoscopy findings can vary. Some patients show signs of external compression, where the tumor pushes against the rectal wall from outside without breaking through the inner lining. Others develop what looks like a polyp inside the rectum. In one documented case, a 12 mm rectal polyp removed during a routine colonoscopy turned out to be metastatic prostate cancer rather than a typical colon polyp.
The distinction matters enormously because treatment for prostate cancer that has spread to the rectum is completely different from treatment for primary rectal cancer. Pathologists use tissue staining and molecular markers on biopsy samples to determine whether a rectal lesion originated from the prostate. PSA levels, which are typically elevated in advanced prostate cancer, can also help point clinicians in the right direction, especially if a patient has a known prostate cancer history.
Survival and Prognosis
The outlook for patients with prostate cancer that has spread to the rectum depends heavily on one factor: whether the cancer still responds to hormone therapy. A study tracking these patients estimated a median overall survival of about 48 months (four years) after rectal involvement was diagnosed. The one-year, three-year, and five-year survival rates were approximately 68%, 54%, and 38%, respectively.
Patients who had not yet received hormone therapy before their rectal involvement was found did considerably better. Their estimated median survival was 70 months (nearly six years), with a five-year survival rate of 55%. Many of these patients were still alive at the end of the study’s follow-up period, with outcomes comparable to other forms of advanced metastatic prostate cancer treated with hormone suppression.
By contrast, patients whose cancer had already become resistant to hormone therapy faced a much grimmer picture, with a median survival of just 5 months after rectal involvement was diagnosed. This stark difference underscores why the timing of rectal spread relative to other treatments plays such a significant role in outcomes.
Why Misdiagnosis Is a Real Risk
Because prostate-to-colon spread is uncommon, it can be mistaken for primary colorectal cancer. The two cancers require fundamentally different treatment strategies. A patient incorrectly diagnosed with colon cancer might undergo surgery or chemotherapy regimens that don’t address the underlying prostate malignancy. If you have a history of prostate cancer and develop new bowel symptoms, or if a rectal biopsy shows unusual features, making sure the pathology team considers a prostate origin can prevent a costly misdiagnosis and get you on the right treatment path faster.